Capture of systemic anticancer medicines in Pharmaceutical Benefits Scheme (PBS) data likely higher than previously reported - Authors' reply

Nicola Creighton, Hanna E. Torvonen, George W. Zhao, David C. Currow

Research output: Contribution to journalLetter

Abstract

Author's reply to Letter to the Editor. We thank Favell et al. for their interest in our Brief Report, Capture of systemic anticancer therapy use by routinely collected health datasets (2020;30(1):e3012004).1
Original languageEnglish
Article numbere3022014
Number of pages4
JournalPublic health research & practice
Volume30
Issue number2
DOIs
Publication statusPublished - 30 Jun 2020
Externally publishedYes

Bibliographical note

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International Licence, which allows others to redistribute, adapt and share this work non-commercially provided they attribute the work and any adapted version of it is distributed under the same Creative Commons licence terms.

Keywords

  • anticancer agents
  • Pharmaceutical Benefits Scheme (PBS)
  • chemotherapy

Fingerprint Dive into the research topics of 'Capture of systemic anticancer medicines in Pharmaceutical Benefits Scheme (PBS) data likely higher than previously reported - Authors' reply'. Together they form a unique fingerprint.

  • Cite this